Anxiety is one of the most cognitively expensive experiences the brain can have. The rumination, the hypervigilance, the constant low-level threat assessment — all of it consumes the prefrontal cortex’s limited processing capacity, leaving less available for the thinking, learning and creative work that actually matters. Chronic anxiety does not just make life less pleasant. It actively impairs the cognitive function that most people experiencing it most want to protect.
The conventional pharmacological responses to anxiety — benzodiazepines, SSRIs, beta-blockers — all carry significant limitations that are well known and frequently experienced. Benzodiazepines work quickly but sedate, impair memory and carry serious dependence risks. SSRIs take four to six weeks to produce meaningful effect, often blunt emotional range alongside the anxiety, and require careful management on discontinuation. Beta-blockers address the physical symptoms without touching the underlying neurological drivers.
Selank was developed as a different kind of answer to the same problem. Selank is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences under the direction of Nikolai Myasoedov. Its sequence extends the natural tetrapeptide Tuftsin with a stabilising Pro-Gly-Pro tail, shielding it from peptidase degradation. What makes Selank unusual among research peptides is its triple pharmacological profile — anxiolytic effects comparable in Russian trials to medazepam, cognitive-supportive nootropic activity and measurable immunomodulation. U.S. News & World Report
That combination — anxiety reduction without sedation, without dependence and without cognitive impairment — is what has made Selank one of the most discussed compounds in the Brain and Mood section of the research peptide community, and what makes it genuinely distinct from every conventional anxiolytic available.
Selank — Thr-Lys-Pro-Arg-Pro-Gly-Pro — is a seven amino acid synthetic peptide whose sequence is based on Tuftsin, a naturally occurring tetrapeptide derived from the Fc portion of immunoglobulin G that plays a role in immune regulation. The Pro-Gly-Pro extension added by the Russian Academy of Sciences researchers protects the peptide from rapid enzymatic degradation, extending its effective biological window beyond what the natural Tuftsin tetrapeptide alone would produce.
Like Semax, Selank is approved in Russia as a prescription medication — specifically for the treatment of generalised anxiety disorder and as an anxiolytic and nootropic agent — giving it a clinical use history that few research peptides in the English-speaking world can match.
N-Acetyl Selank adds an acetyl group to the N-terminus of the base peptide, improving stability, enhancing blood-brain barrier penetration and producing a more potent effect per unit dose. The relationship between N-Acetyl Selank and base Selank mirrors the relationship between N-Acetyl Semax and base Semax — the acetylated form is more potent, more stable and more appropriate for those who want maximum effect at lower absolute doses.
Researchers have proposed two mechanisms of Selank’s actions. Its cognition-enhancing effects may be due to an ability to influence the brain’s levels of noradrenaline, serotonin and dopamine, three neurotransmitters with well-documented relationships to vigilance, attention, learning, memory and the motivation toward cognitive effort. Meanwhile its anxiolytic effects appear to be GABAergic, relating to the neurotransmitter GABA. Exploring Peptides
As a mood stabiliser, Selank functions similarly to benzodiazepine tranquilisers — it modulates GABA-A receptors to increase inhibitory action on neuronal excitability, facilitating a state of calm. Importantly however, Selank does not cause the sedation, memory impairment or dependence that benzodiazepines produce. Exploring Peptides
This distinction is the most practically important thing about Selank’s mechanism. It engages the same inhibitory GABA system that benzodiazepines use, but through a different binding site and with a different receptor interaction profile. The net result is the calming of overexcited neural activity without the broad central nervous system depression that makes benzodiazepines incompatible with cognitive performance. The anxiety quiets. The mind remains.
With continued use, Selank has demonstrated long-term improvements in anxiety symptoms, suggesting a restoration of balance in the HPA axis and sustained modulation of the stress response. This is a different and deeper mechanism from the acute GABA modulation — it addresses the underlying dysregulation of the stress response system that chronic anxiety both reflects and perpetuates. For someone whose anxiety is driven by a chronically overactivated HPA axis rather than acute situational stress, this recalibration effect is more meaningful than any acute anxiolytic mechanism. My WordPress
Selank affects how the brain handles serotonin, dopamine and norepinephrine. Serotonin shifts help mood. Dopamine and norepinephrine shifts help focus, motivation and learning. These monoaminergic effects are what give Selank its nootropic dimension — it is not simply an anxiolytic that happens to avoid sedation. It actively supports the neurotransmitter systems that cognitive performance depends on, which is why the research community consistently reports improvements in focus, memory and mental endurance alongside the anxiety reduction. U.S. News & World Report
BDNF Upregulation
Intranasal Selank quickly raises BDNF levels in the hippocampus in animal studies. This neurotrophic dimension, shared with Semax though less pronounced, adds a neuroprotective element to Selank’s profile — supporting the hippocampal health that chronic stress and chronic anxiety are known to impair through cortisol-mediated mechanisms. Yahoo!
The Tuftsin origin of Selank’s sequence gives it a biological relationship with immune regulation that most compounds in this library do not share. Selank has demonstrated effects on immune cell activity and cytokine balance in research settings — an area that is attracting increasing interest given the well-established bidirectional relationship between immune function and mental health.
The parent peptide has a plasma half-life of 2 to 3 minutes. Downstream effects via active metabolites, gene expression changes and enkephalinase inhibition persist for hours to days, which is why dosing frequency is set by downstream windows rather than plasma kinetics. Enkephalinase inhibition — preventing the breakdown of the brain’s natural enkephalin peptides — contributes to the mood-stabilising and analgesic effects that make Selank’s profile broader than its simple GABAergic mechanism alone would suggest. U.S. News & World Report
The evidence base for Selank is the most substantial of any anxiolytic peptide in this library — which is a meaningful statement given how limited the human evidence is for most compounds in this space.
Selank has the most human data of any anxiety peptide. Anecdotal reports and limited human data suggest Selank produces anxiolytic effects within 30 to 90 minutes of intranasal administration, significantly faster than SSRIs which take 4 to 6 weeks for full effect. PeptideKnow
The Russian clinical programme for Selank is the primary source of controlled human evidence, with trials demonstrating anxiolytic efficacy comparable to medazepam — a benzodiazepine class anxiolytic — without the sedation, cognitive impairment or dependence liability. This direct comparison with a conventional anxiolytic in a controlled clinical setting is a meaningful piece of evidence that goes beyond the preclinical data that most research peptides rely on.
Russian clinical data report no withdrawal syndrome, no tolerance escalation and no rebound anxiety after discontinuation. Mechanistically, Selank does not engage the benzodiazepine binding site on GABA-A, which is the molecular basis of benzodiazepine dependence. U.S. News & World Report
A 2016 study in Frontiers in Pharmacology examined Selank’s effects on gene expression in GABAergic neurotransmission pathways, providing mechanistic confirmation of the GABAergic mechanism through genetic analysis rather than simply behavioural observation.
The honest caveat that this site maintains throughout applies here as it does to every compound in the library. No anxiety peptide has completed a Phase 3 randomised controlled trial meeting FDA or EMA standards for anxiolytic approval. The Russian clinical evidence is meaningful and encouraging. The absence of large-scale Western controlled trials meeting current regulatory standards means those engaging with Selank as a research compound are doing so on the basis of Russian clinical data, consistent preclinical evidence and accumulated real-world experience — which is substantial but not the same as the standard that would be required for Western pharmaceutical approval. PeptideKnow
These two compounds are frequently discussed together — including on this site — and the relationship between them is worth establishing clearly because they address different primary needs despite sharing a Russian research origin and an intranasal administration route.
Selank is anxiety-first. It works mainly through GABA and serotonin pathways. Semax is focus-first. It works mainly through BDNF and dopamine pathways. They are often paired together as the Russian Nootropic Stack because their profiles complement each other. Yahoo!
The practical decision between them is straightforward. Someone whose primary concern is anxiety, stress reactivity or emotional dysregulation that is impairing their cognitive performance should start with Selank. Someone whose primary concern is cognitive performance, focus, memory and BDNF-driven neuroplasticity with anxiety as a secondary concern should start with Semax. Someone dealing meaningfully with both — which is extremely common, given the well-established relationship between chronic anxiety and cognitive impairment — is the ideal candidate for the combined Russian Nootropic Stack.
Who Is Selank Most Relevant For?
Selank is relevant to a clearly definable group — and specifying it precisely makes the compound significantly more useful than treating it as a general anxiety remedy.
It is most relevant for people in their 30s to 60s who experience chronic anxiety or chronic stress that is measurably impacting their cognitive performance, emotional wellbeing and quality of life, and who have either found conventional anxiolytic approaches insufficient, too side-effect-laden or simply incompatible with the kind of mental sharpness they need to maintain professionally and personally.
It is specifically relevant for high-functioning people who carry a significant anxiety burden but cannot afford the cognitive costs that conventional anxiolytics impose — professionals, executives, academics, creatives and anyone whose livelihood and identity are tied to their cognitive performance. The combination of genuine anxiolytic effect and preserved or enhanced cognitive function is precisely what this group most needs and most consistently fails to find in conventional approaches.
It is relevant for people who have made meaningful lifestyle changes to manage anxiety — exercise, sleep optimisation, stress management practices — and want a compound that complements those foundations rather than substituting for them. Selank works best in someone who is already doing the work. It amplifies the anxiety-reducing effects of a well-managed lifestyle rather than compensating for an unmanaged one.
It is less appropriate for people seeking acute sedation or the kind of pronounced immediate anxiolytic effect that benzodiazepines produce. Selank works more subtly and more gradually — calming the underlying neurological drivers of anxiety rather than suppressing the nervous system acutely. For someone in a crisis requiring immediate pharmacological intervention, Selank is not the right tool.
Base Selank — Intranasal Protocol:
N-Acetyl Selank — Intranasal Protocol:
Community protocols typically start at 250mcg Selank plus 300mcg Semax per day and titrate each compound independently. The two compounds are administered separately — Selank and Semax are not mixed in the same nasal spray bottle. Each is reconstituted and stored individually, and the doses are typically administered in the same morning session with a brief interval between them. Yahoo!
As with Semax, intranasal Selank requires sterile saline or preservative-free sterile water rather than bacteriostatic water. Benzyl alcohol, the preservative in bacteriostatic water, irritates nasal mucosal membranes and is inappropriate for intranasal use.
Using a 5mg (5,000mcg) vial:
Add 2ml of sterile saline:
For most people adding 2ml to a 5mg vial creates the most practical working concentration — 250mcg per spray aligns directly with the standard daily dose.
Transfer the reconstituted solution into the nasal atomiser. Administer one spray per nostril for a bilateral dose, or into a single nostril if a lower unilateral dose is preferred. Breathe gently through the nose after administration rather than sniffing sharply. Alternate nostrils between administrations where possible to prevent localised mucosal irritation.
Storage
Reconstituted Selank solution should be refrigerated at 2 to 8 degrees Celsius and used within 14 days given the use of sterile saline rather than bacteriostatic water. Lyophilised powder should be stored frozen until ready for reconstitution.
The supplements that most coherently support Selank’s anxiolytic, neurotrophic and immunomodulatory mechanism are those that complement the GABA system, support the monoaminergic neurotransmitters the compound modulates and maintain the neurochemical environment in which its effects are most productive.
Magnesium glycinate is the most directly relevant supplement alongside Selank. Magnesium is an essential cofactor for GABA receptor function and GABA synthesis — inadequate magnesium directly impairs the GABAergic inhibitory system that Selank is working to modulate. Magnesium glycinate specifically has superior brain penetration compared to other magnesium forms and produces calming effects in its own right through its GABA receptor interactions, creating a genuinely complementary and synergistic combination.
L-Theanine supports the GABAergic and serotonergic calming mechanisms that Selank activates, through a complementary pathway that enhances alpha brainwave activity associated with calm focus. The combination of Selank’s receptor-level modulation and L-Theanine’s complementary calming effects is well-regarded in the research community.
Ashwagandha supports HPA axis regulation through cortisol-modulating mechanisms that complement Selank’s own HPA recalibration effects — addressing the stress response system from both a peptide and an adaptogenic angle simultaneously.
Omega-3 fatty acids support neuronal membrane integrity, BDNF signalling and the anti-inflammatory environment in which Selank’s neurotrophic effects operate most effectively.
Vitamin B complex supports the neurotransmitter synthesis pathways — serotonin, dopamine and norepinephrine — that Selank’s monoaminergic modulation works through. B6 is particularly relevant as a cofactor in serotonin synthesis.
Zinc supports immune function and the immunomodulatory dimension of Selank’s Tuftsin-derived mechanism — the immune-brain axis that this compound engages through its unique ancestral sequence.
The nutritional approach that best supports Selank’s anxiolytic and cognitive mechanisms provides both the precursors for the neurotransmitters it modulates and the anti-inflammatory environment in which its GABAergic and HPA axis effects are most productive.
Fermented foods — live yoghurt, kefir, sauerkraut, kimchi — support the gut microbiome whose relationship with the GABAergic system and the HPA axis is increasingly well-established. The gut produces significant quantities of GABA and serotonin precursors, and a healthy microbiome supports both the neurotransmitter balance and the HPA axis regulation that Selank is working to optimise from the neurological side simultaneously.
Tryptophan-rich foods support serotonin synthesis — turkey, oats, eggs, nuts, seeds and dairy all deliver meaningful tryptophan alongside the complete protein that overall neurological health requires.
Dark leafy greens deliver magnesium, folate and the full spectrum of B vitamins that neurotransmitter synthesis and GABA function depend on. Spinach, kale and Swiss chard are among the most nutrient-dense options for neurological support.
Chamomile tea has a genuine evidence base for mild GABAergic calming effects through apigenin binding — creating a gentle dietary complement to Selank’s GABA receptor modulation that is particularly relevant in the evening hours.
Oily fish two to three times per week delivers the DHA that neuronal membrane health, BDNF signalling and the anti-inflammatory environment require — particularly relevant given Selank’s BDNF-upregulating dimension.
Caffeine in excess, alcohol and refined sugars all disrupt the GABA-glutamate balance, impair sleep architecture and promote the neuroinflammation that works against both the anxiolytic and nootropic effects Selank is working to produce.
Sleep quality is the lifestyle factor most directly relevant to Selank’s primary application. Anxiety and sleep disruption form one of the most vicious biological cycles in mental health — anxiety impairs sleep, sleep deprivation amplifies anxiety, and the chronic HPA axis dysregulation that results perpetuates both. Selank’s HPA axis recalibration is most meaningful when combined with active sleep hygiene practices that allow the nervous system the restoration it needs to consolidate the anxiolytic effects the compound is producing.
Mindfulness and breathing practices — structured breathwork, meditation, yoga nidra — directly activate the parasympathetic nervous system in ways that complement Selank’s GABAergic calming mechanism. The combination of a compound recalibrating the neurological anxiety drivers and a practice that trains the nervous system’s calming response represents a more comprehensive approach to anxiety management than either provides independently.
Physical exercise — particularly aerobic activity — is one of the most robustly evidenced natural anxiolytics available, working through endorphin release, cortisol regulation and BDNF upregulation that directly complement Selank’s mechanisms. The person who combines Selank with regular aerobic exercise will find the combined effect on anxiety and cognitive wellbeing meaningfully greater than either produces alone.
Social connection is worth specific mention in the context of a compound derived from Tuftsin, which has immunological roots in the social bonding and cooperative behaviour that immune health supports. The research on social connection as an HPA axis regulator is substantial — genuine human connection produces measurable cortisol reduction and GABA-mediated calming effects that amplify what Selank is doing neurochemically.
Reducing caffeine intake is worth deliberate attention for anyone using Selank for anxiety. High caffeine consumption directly antagonises GABA receptor function and elevates cortisol — both of which work against Selank’s primary mechanisms. Reducing caffeine to moderate levels during a Selank protocol is one of the most impactful and accessible lifestyle adjustments available.
Semax is the most natural, most complementary and most commonly used pairing with Selank — the Russian Nootropic Stack that has become one of the most discussed combinations in the nootropic research community. Semax addresses cognitive performance and BDNF upregulation. Selank addresses anxiety reduction and HPA axis recalibration. The two compounds occupy genuinely different primary mechanisms without meaningful overlap, and the combination produces a cognitive and emotional profile that neither generates independently — focus and clarity from Semax, calm and resilience from Selank.
BPC-157 complements Selank through the gut-brain axis — BPC-157’s gut protective and anti-inflammatory effects support the gut microbiome and intestinal integrity that are directly relevant to the GABA and serotonin production pathways Selank is working through. For anyone whose anxiety has a significant gut-health dimension, the combination of BPC-157 addressing the gut side and Selank addressing the neurological side represents a genuinely comprehensive approach.
Epithalon pairs coherently with Selank for older researchers whose anxiety concerns overlap with longevity and healthy ageing goals — Epithalon’s pineal function support and sleep architecture improvement directly complement Selank’s HPA axis recalibration and the improved sleep that follows.
DSIP is sometimes used alongside Selank specifically for the anxiety-sleep relationship — DSIP supporting the delta-wave sleep architecture in which the nervous system restoration that Selank’s recalibration depends on occurs most effectively.
Selank is the most evidence-backed anxiolytic peptide in this library and the only one with Russian prescription medicine status for anxiety treatment. Its combination of genuine anxiolytic efficacy, preserved cognitive function and absence of dependence or withdrawal represents something that conventional pharmacology has not consistently achieved — and that combination is what makes it worth taking seriously.
The experience most consistently reported by those who use Selank within appropriate protocols and with realistic expectations is a progressive quieting of the ambient anxiety that has previously consumed cognitive bandwidth, alongside a clarity and ease of thinking that anxiety had been impeding. It is not a dramatic sedation. It is not a chemical happiness. It is, at its best, the cognitive experience of a mind that is no longer spending significant resources managing threat signals that were not serving any useful purpose.
Used consistently within a 10-day cycle structure, at appropriate doses through intranasal administration with sterile saline, alongside the sleep, exercise and lifestyle practices that complement its mechanism, and ideally combined with Semax for the full Russian Nootropic Stack — Selank delivers on the remarkable clinical reputation it has earned across three decades of use in Russian psychiatric medicine.
No items in your cart. Go on, fill it up with something you love!
Start Shopping Now